加兰他敏用于治疗阿尔茨海默病和轻度认知障碍。 - Suppr

Suppr

超能文献

Galantamine for Alzheimer's disease and mild cognitive impairment.

作者信息

Cusi Cristina, Cantisani Teresa Anna, Celani Maria Grazia, Incorvaia Barbara, Righetti Enrico, Candelise Livia

出版信息

Neuroepidemiology. 2007;28(2):116-7. doi: 10.1159/000101510. Epub 2007 Apr 4.

DOI:10.1159/000101510

PMID:17409773

Abstract

摘要

相似文献

Galantamine for Alzheimer's disease and mild cognitive impairment.加兰他敏用于治疗阿尔茨海默病和轻度认知障碍。

Neuroepidemiology. 2007;28(2):116-7. doi: 10.1159/000101510. Epub 2007 Apr 4.

A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.多奈哌齐与加兰他敏治疗阿尔茨海默病认知症状的比较：一项荟萃分析。

Hum Psychopharmacol. 2005 Apr;20(3):183-7. doi: 10.1002/hup.676.

[Alzheimer drugs for mild cognitive impairment].用于轻度认知障碍的阿尔茨海默病药物

Neuropsychiatr. 2007;21(3):230-3.

Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).加兰他敏治疗合并脑血管疾病的阿尔茨海默病：一项随机对照试验（GAL-INT-6）的疗效分析

J Psychopharmacol. 2008 Sep;22(7):761-8. doi: 10.1177/0269881107083028. Epub 2008 Feb 28.

An unusual case of nightmares with galantamine.

J Am Geriatr Soc. 2009 Mar;57(3):565. doi: 10.1111/j.1532-5415.2009.02157.x.

The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease.加兰他敏治疗重度阿尔茨海默病安全性和有效性的SERAD研究。

Lancet Neurol. 2009 Jan;8(1):22-3. doi: 10.1016/S1474-4422(08)70262-X. Epub 2008 Nov 29.

[Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].阿尔茨海默病患者的药物治疗：与抗痴呆药物加兰他敏的相互作用

Med Monatsschr Pharm. 2006 Jun;29(6):222-4.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.加兰他敏与美金刚联合治疗阿尔茨海默病的原理。

J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. doi: 10.1177/0091270006288735.

Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.加兰他敏对老年阿尔茨海默病患者心脏功能影响的评估。

Am J Geriatr Pharmacother. 2010 Oct;8(5):454-9. doi: 10.1016/j.amjopharm.2010.09.001.

The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.在加兰他敏治疗阿尔茨海默病的 VISTA 临床试验中，ADAS-cog 和临床上有意义的变化。

Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201. doi: 10.1002/gps.2319.

引用本文的文献

Succinimide Derivatives as Acetylcholinesterase Inhibitors-In Silico and In Vitro Studies.琥珀酰亚胺衍生物作为乙酰胆碱酯酶抑制剂的计算机模拟和体外研究

Curr Issues Mol Biol. 2024 May 22;46(6):5117-5130. doi: 10.3390/cimb46060307.

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues.以神经退行性疾病为重点的治疗性药物重新定位：威胁与问题

Front Pharmacol. 2022 Oct 3;13:1007315. doi: 10.3389/fphar.2022.1007315. eCollection 2022.

In Vitro and In Silico Kinetic Studies of Patented 1,7-diEthyl and 1,7-diMethyl Aminoalkanol Derivatives as New Inhibitors of Acetylcholinesterase.专利的 1,7-二乙基和 1,7-二甲基氨基烷醇衍生物作为乙酰胆碱酯酶新抑制剂的体外和计算动力学研究。

Int J Mol Sci. 2021 Dec 27;23(1):270. doi: 10.3390/ijms23010270.

The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验